These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2147120)

  • 1. Inhibition of low calcium induced epileptiform discharges in the hippocampus by dopamine D1 receptor agonist, SKF 38393.
    Smiałowski A
    Brain Res; 1990 Sep; 528(1):148-50. PubMed ID: 2147120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sleep during acute dopamine D1 agonist SKF 38393 or D1 antagonist SCH 23390 administration in rats.
    Monti JM; Fernández M; Jantos H
    Neuropsychopharmacology; 1990 Jun; 3(3):153-62. PubMed ID: 2141985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repeated administration of SCH 23390 enhances the SKF 38393-induced inhibition in the rat hippocampus.
    Smiałowski A; Bijak M
    Neuroscience; 1989; 28(2):409-12. PubMed ID: 2564173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracellular studies on the dopamine-induced firing inhibition of neostriatal neurons in vitro: evidence for D1 receptor involvement.
    Calabresi P; Mercuri N; Stanzione P; Stefani A; Bernardi G
    Neuroscience; 1987 Mar; 20(3):757-71. PubMed ID: 2955246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. D1 agonists suppress zero Mg(2+)-induced epileptiform activity in the rat cingulate cortex slice.
    Alam AM; Starr MS
    Neuroreport; 1993 Oct; 5(1):78-80. PubMed ID: 7506591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electrophysiological effects of dopamine receptor stimulation in the hippocampus of Acomys cahirinus.
    Bijak M; Danek L; Smiałowski A
    Pol J Pharmacol Pharm; 1988; 40(5):535-41. PubMed ID: 2908137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Excitatory and inhibitory action of dopamine on hippocampal neurons in vitro. Involvement of D2 and D1 receptors.
    Smiałowski A; Bijak M
    Neuroscience; 1987 Oct; 23(1):95-101. PubMed ID: 2960914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of the 5-HT1C receptor expressed in Xenopus oocytes by the benzazepines SCH 23390 and SKF 38393.
    Briggs CA; Pollock NJ; Frail DE; Paxson CL; Rakowski RF; Kang CH; Kebabian JW
    Br J Pharmacol; 1991 Dec; 104(4):1038-44. PubMed ID: 1687364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the D1-dopamine agonists SKF-38393 and A-68930 in neonatal 6-hydroxydopamine-lesioned rats: behavioral effects and induction of c-fos-like immunoreactivity.
    Johnson KB; Criswell HE; Jensen KF; Simson PE; Mueller RA; Breese GR
    J Pharmacol Exp Ther; 1992 Aug; 262(2):855-65. PubMed ID: 1354257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A mechanism underlying dopamine D1 and D2 receptor-mediated inhibition of dopaminergic neurones in the ventral tegmental area in vitro.
    Momiyama T; Todo N; Sasa M
    Br J Pharmacol; 1993 Aug; 109(4):933-40. PubMed ID: 8104652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repeated treatment with imipramine enhances the excitatory response of hippocampal neurons to dopamine.
    Smiałowski A; Bijak M
    Neuroscience; 1987 Dec; 23(3):1021-4. PubMed ID: 2963971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine control of seizure propagation: intranigral dopamine D1 agonist SKF-38393 enhances susceptibility to seizures.
    Turski WA; Cavalheiro EA; Ikonomidou C; Bortolotto ZA; Klockgether T; Turski L
    Synapse; 1990; 5(2):113-9. PubMed ID: 2137942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of dopamine D1 receptors enhances long-term depression of synaptic transmission induced by low frequency stimulation in rat hippocampal CA1 neurons.
    Chen Z; Fujii S; Ito K; Kato H; Kaneko K; Miyakawa H
    Neurosci Lett; 1995 Mar; 188(3):195-8. PubMed ID: 7609907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurophysiological investigation of effects of the D-1 agonist SKF 38393 on tonic activity of substantia nigra dopamine neurons.
    Carlson JH; Bergstrom DA; Weick BG; Walters JR
    Synapse; 1987; 1(5):411-6. PubMed ID: 2975067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. D1/D5 receptor agonists induce a protein synthesis-dependent late potentiation in the CA1 region of the hippocampus.
    Huang YY; Kandel ER
    Proc Natl Acad Sci U S A; 1995 Mar; 92(7):2446-50. PubMed ID: 7708662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SKF 38393 alters the rate-dependent D2-mediated inhibition of nigrostriatal but not mesoaccumbens dopamine neurons.
    Kelland MD; Freeman AS; Chiodo LA
    Synapse; 1988; 2(4):416-23. PubMed ID: 2973142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of chronic treatment with selective agonists on the subtypes of dopamine receptors.
    Subramaniam S; Lucki I; McGonigle P
    Brain Res; 1992 Feb; 571(2):313-22. PubMed ID: 1351781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absence of D1 dopamine receptors that stimulate prolactin release in the rat pituitary.
    Cocchi D; Ingrassia S; Rusconi L; Villa I; Müller EE
    Eur J Pharmacol; 1987 Oct; 142(3):425-9. PubMed ID: 2962879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-methyl-D-aspartate receptor blockade attenuates D1 dopamine receptor modulation of neuronal activity in rat substantia nigra.
    Huang KX; Bergstrom DA; Ruskin DN; Walters JR
    Synapse; 1998 Sep; 30(1):18-29. PubMed ID: 9704877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The atypical dopamine D1 receptor agonist SKF 83959 induces striatal Fos expression in rats.
    Wirtshafter D; Osborn CV
    Eur J Pharmacol; 2005 Dec; 528(1-3):88-94. PubMed ID: 16324697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.